EZH2 and B-cell chronic lymphocytic leukemia: A recent study [15] from our group implicated for the first time EZH2 in the pathophysiology of chronic lymphocytic leukemia (CLL), a chronic malignancy of mature B cells [16], displaying remarkable clinical and biological heterogeneity.